Patents by Inventor Martine Rothblatt

Martine Rothblatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
    Publication number: 20030166728
    Abstract: The present invention is directed to a pharmaceutical composition containing a cancer-treating effective amount of a class of prostacyclin derivatives, and a pharmaceutically acceptable carrier, and to kits and methods of employing the same for the treatment of cancer.
    Type: Application
    Filed: January 16, 2002
    Publication date: September 4, 2003
    Inventors: Robert Shorr, Martine Rothblatt
  • Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
    Publication number: 20030108512
    Abstract: The invention is directed to a pharmaceutical composition containing a cancer-treating effective amount of a prostaglandin compound and analogs thereof having a metabolic rate slowing group attached thereto, and a pharmaceutically acceptable carrier, and methods of employing the same for the treatment of cancer.
    Type: Application
    Filed: December 10, 2001
    Publication date: June 12, 2003
    Inventors: Robert Shorr, Martine Rothblatt, Michael Bentley, Xuan Zhao
  • Inhibitors of endothelin-1 synthesis
    Publication number: 20030109480
    Abstract: Sequences in human preproendothelin-1 mRNA are described against which antisense oligonucleotides can be used to inhibit the synthesis of endothelin-1. This inhibition of endothelin-1 synthesis may be used to treat diseases where excess production of endothelin-1 is an underlying cause of the symptoms.
    Type: Application
    Filed: November 18, 2002
    Publication date: June 12, 2003
    Applicant: United Therapeutics Corporation
    Inventors: Roger Corder, Adrian P.L. Smith, Timothy W. Higenbottam, Martine Rothblatt, Sir John Vane, Delphine Dominique Marthe Lees
  • Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
    Patent number: 6242482
    Abstract: Prostaglandin and analogs thereof which include protective groups attached to at least one site which are pharmaceutically acceptable and which are capable of slowing the metabolic rate of the active groups for administration to a warm blooded animal for the treatment of congestive heart failure.
    Type: Grant
    Filed: June 5, 2000
    Date of Patent: June 5, 2001
    Assignee: United Therapeutics Corporation
    Inventors: Robert Shorr, Martine Rothblatt, Michael D. Bentley, Xuan Zhao
  • System for providing global portable internet access using low earth orbit satellite and satellite direct radio broadcast system
    Patent number: 6105060
    Abstract: A system for providing global and portable Internet access to low cost user terminals comprises an Internet service provider gateway and a broadcast station for providing multimedia information from the gateway to the user terminals via a direct radio broadcast geostationary satellite. User terminals each comprise a direct radio broadcast receiver and a transceiver for communicating with a low earth orbit (LEO) satellite. User terminals transmit Internet access requests, menu selections and other backhaul signals to the gateway via the transceiver. The broadcast station transmits information requested by the user from the gateway to a specific user terminal by providing identification codes in the broadcast programs. The user terminals are programmable to receive all broadcast programs but to demodulate and demultiplex only those broadcast channels addressed to the user terminal. Internet access is available simultaneously with reception of satellite direct broadcasts of audio programs.
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: August 15, 2000
    Assignee: WorldSpace, Inc.
    Inventor: Martine A. Rothblatt
  • Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease
    Patent number: 6054486
    Abstract: An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene) -13,14-dihydro-prostaglandin F.sub.1.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: April 25, 2000
    Assignee: United Technology Corporation
    Inventors: James W. Crow, Shelmer D. Blackburn, Jr., Robert Roscigno, Michael Wade, Gilles Cloutier, Martine Rothblatt